Founder
CurrentUbuntu Research Inc. is formed with a mission to bring highly innovative therapies to patients in an expedient, sustainable and contemporaneous manner. Our goal is to serve patient communities by partnering with emerging biotech organizations that are focused on the development of cellular and gene transfer therapeutics. DIMENSION-T, our subscription-oriented services platform offer bespoke solutions for companies to conceive and create robust clinical development strategies, efficient resource plans and generate core capabilities required to accelerate clinical development. We aspire to translate the benefits of optimized risk, cost and time of drug development into better and more meaningful outcomes for patients.